G.-Q. Wang

A pilot randomized controlled trial of dual‐plasmid HBV DNA vaccine mediated by in vivo electroporation in chronic hepatitis B patients under lamivudine chemotherapy

J. Chen, Fangying Yang, Y.-Y. Yu, 2012, Journal of viral hepatitis.

Prognostic value of clinical and immunological markers in acute phase of SFTS virus infection.

H. Yu, Y. Wang, M. Liang, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Telbivudine treatment is associated with high hepatitis B e antigen seroconversion and immune modulatory effects in chronic hepatitis B patients

G.-Q. Wang, Y. Ding, Yong-hui Dong, 2013, Journal of viral hepatitis.

Rapid downregulation of programmed death‐1 and interferon‐γ‐inducible protein‐10 expression is associated with favourable outcome during antiviral treatment of chronic hepatitis B

J. Chen, Y. Wang, Y-z Liu, 2013, Journal of viral hepatitis.

Dynamic analysis of hepatitis B virus DNA and its antigens in 2.2.15 cells

W. Piao, M. Yu, Y. Wang, 2004, Journal of viral hepatitis.

P057: Efficacy and safety of Peginterferon alfa‐2b (40 kD, Y Shape) (Pegberon) in HBeAg‐ positive CHB patients — a phase III, randomized, multicenter, positive‐controlled, open‐label clinical study

J. Shang, G. Gong, Q. Xie, 2015 .

PU.1 antisense lncRNA against its mRNA translation promotes adipogenesis in porcine preadipocytes.

Gongshe Yang, W. Pang, N. Wei, 2015, Animal genetics.

Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin in Asian patients with genotype 1b chronic hepatitis C virus infection and compensated cirrhosis: ONYX-II post-treatment week 24 results

J. Kao, S. Paik, C. Chu, 2017 .